RT/RP vs RT/ADT OCSS (overall cancer-... - Advanced Prostate...

Advanced Prostate Cancer

21,008 members26,183 posts

RT/RP vs RT/ADT OCSS (overall cancer-specific survival)

8 Replies

What am I missing? Looks like RP with RT OCSS is a fraction of OS (overall survival). I have looked at multiple studies and they all seem to show the same type of thing.

a.10-year survival after RT/ADT or RT/RP (comparing overall mortality (PCa, cardiac, etc) to PCa mortality for RT/ADT vs. RT/RP)

"The ten-year prostate cancer–specific survival rate for men undergoing radical prostatectomy plus radiotherapy was 89 percent compared to 74 percent in the group undergoing radiotherapy plus androgen deprivation therapy. Overall ten-year survival rates were 64 and 48 percent, respectively."

b.mskcc.org/clinical-updates/...

Read more about...
8 Replies
Tall_Allen profile image
Tall_Allen

What you're missing is level of evidence.

mrscruffy profile image
mrscruffy

Where they for comparable age groups?

in reply to mrscruffy

The one posted is for 65+. I'm 59 so my stats would be different. Another thing that inherently confounds any study of 10-year results is that, if it is based on actual results, the technology used is 10+ years old.

From: grandroundsinurology.com/th...

RT results
mrscruffy profile image
mrscruffy in reply to

The other thing that I wonder about is were they diagnosed early(I was because my dad passed from this crap) or were they diagnosed way late. Have a friend diagnosed same time as me but it was way further along. He is in bad shape I am great relatively speaking

doc1947g profile image
doc1947g in reply to

It is for Brachytherapy and for men =< 60 y.o.

in reply to doc1947g

Thanks.

I clarified my response.

Don_1213 profile image
Don_1213

As TA said - level of evidence. I'd also argue the study is flawed simply by the age difference typical between RP/RT patients and RT/ADT patients. Especially since this mornings readings were pretty convincing on showing that increasing age = higher risk cancer.

From this study:

"Observational Study Limitations

Since this analysis was observational and patients were not randomized to treatment approaches, the findings are directional. SEER data is designed for billing purposes, so crucial information that may influence the results, such as radiation dosage or whether patients received nerve-sparing surgery, is not precisely captured. Using Medicare claims to measure adverse events is a crude estimate, since codes may not be specific enough to capture diagnoses or procedures related to complications. (1)

Finally, it is important to note that since 2009, the last year for data capture in this observational study, there have been many advances in prostate cancer surgery and radiotherapy approaches that have served to improve outcomes further while reducing adverse events, such as erectile dysfunction and urinary incontinence."

So the data used is rather non-specific and basically flawed, out of date, and time has improved treatments overall. Making the paper pretty much useless for any intelligent decisions. But that's just me..

in reply to Don_1213

I agree that 10 year OS data is inherently using 10+-year-old technology. The second study I posted is for guys under 60. I would venture a guess that if old tech used on older guys shows an 80% CSS that new tech on a guy under 60 would show a better CSS.

I'm trying to read between the lines but often times we have to make decisions based on imperfect inputs. I wondered if there was anything glaring that stood out like perhaps I made a mistake in what CSS and OS mean.

You may also like...

RP vs RT - another piece

study compared survival outcomes and adverse effects associated with radical prostatectomy (RP)...

PSA Nadir After RT+ADT for Prostate Cancer Predicts Outcomes

received RT alone, RT plus short-term ADT, and RT plus long-term ADT, respectively. The rates for...

Surgery + Radiation for Advanced PCa Offers Better Survival than RT + xRT

improved overall survival compared with primary treatment consisting of radiotherapy plus androgen...

RT with ADT Relogolix (Orgovyx) vs Enzalutamide (Xtandi) Side Effect Differences?

the last 3 years are showing administration of Xtandi during Radiotherapy has shown outcomes as...

RP vs radiation. Survival from time of metastasis.

alone had 77% higher overall mortality after developing metastatic disease ... compared with men...